Literature DB >> 23270440

Comparison of scoring systems for assessment of acute mountain sickness.

Dale R Wagner1, Masaru Teramoto, Jonathan R Knott, Jack P Fry.   

Abstract

The purpose of this study was to compare three commonly used scoring systems of acute mountain sickness (AMS)-the 5-item Lake Louise Self-report (LLS), the 11-item abridged version of the Environmental Symptoms Questionnaire (ESQ-III), and a 100 mm visual analog scale (VAS)-on climbers (N=63; 34.6±9.9 years) making a 1-day ascent of a 5640 m peak after a rest of ~10 h at 4260 m. The prevalence of AMS was 63% when defined as LLS ≥3, 49% when defined as either LLS ≥5 or ESQ-III ≥0.7, and 41% when defined as the combined LLS and ESQ-III criteria. Despite the agreement in prevalence between the LLS ≥5 and ESQ-III ≥0.7, there was a discrepancy in AMS classification in 16% of the cases. A VAS cut-off point corresponding to the combined LLS and ESQ-III criteria was 16 mm. The sensitivity and specificity of the VAS for diagnosing AMS compared to combined LLS and ESQ-III criteria were 85% and 92%, respectively. All of the scoring systems were significantly correlated (τ=0.60 to 0.73, p<0.01); however, residual scores were large. We cannot recommend interchanging the diagnostic results from the LLS, ESQ-III, and VAS, and standardization is needed for the administration of the VAS.

Entities:  

Mesh:

Year:  2012        PMID: 23270440     DOI: 10.1089/ham.2012.1030

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  12 in total

1.  Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude?

Authors:  Veronika Leichtfried; Daniel Basic; Martin Burtscher; Raffaella Matteucci Gothe; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sleep Breath       Date:  2015-06-02       Impact factor: 2.816

2.  Evaluation of the visual analog score (VAS) to assess acute mountain sickness (AMS) in a hypobaric chamber.

Authors:  Jialin Wu; Yu Chen; Yongjun Luo
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

3.  Acute Mountain Sickness Symptoms Depend on Normobaric versus Hypobaric Hypoxia.

Authors:  Dana M DiPasquale; Gary E Strangman; N Stuart Harris; Stephen R Muza
Journal:  Biomed Res Int       Date:  2016-10-25       Impact factor: 3.411

4.  Subjective assessment of acute mountain sickness: investigating the relationship between the Lake Louise Self-Report, a visual analogue scale and psychological well-being scales.

Authors:  Anika Frühauf; Martin Burtscher; Elena Pocecco; Martin Faulhaber; Martin Kopp
Journal:  Springerplus       Date:  2016-09-22

Review 5.  Sex-based differences in the prevalence of acute mountain sickness: a meta-analysis.

Authors:  Yun-Peng Hou; Jia-Lin Wu; Chao Tan; Yu Chen; Rui Guo; Yong-Jun Luo
Journal:  Mil Med Res       Date:  2019-12-09

6.  Impact of 2 days of staging at 2500-4300 m on sleep quality and quantity following subsequent exposure to 4300 m.

Authors:  Janet E Staab; Stephen R Muza; Charles S Fulco; Sean P Andrew; Beth A Beidleman
Journal:  Physiol Rep       Date:  2021-11

7.  Acute mountain sickness and sleep disturbances differentially influence cognition and mood during rapid ascent to 3000 and 4050 m.

Authors:  Peter S Figueiredo; Ingrid V Sils; Janet E Staab; Charles S Fulco; Stephen R Muza; Beth A Beidleman
Journal:  Physiol Rep       Date:  2022-02

8.  Morphological Brain Changes after Climbing to Extreme Altitudes--A Prospective Cohort Study.

Authors:  Raimund Kottke; Jacqueline Pichler Hefti; Christian Rummel; Martinus Hauf; Urs Hefti; Tobias Michael Merz
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

9.  The influence of hypoxia and prolonged exercise on attentional performance at high and extreme altitudes: A pilot study.

Authors:  Mirjam Limmer; Petra Platen
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

10.  Prophylaxis of ibuprofen in acute mountain sickness: A protocol for systematic review and meta-analysis.

Authors:  Hai Yi; Kuiying Wang; Xinyu Gan; Li Li; Qian Zhang; Jiao Xiang; Xiuwei Yuan; Yugang Zhang; Yonghua Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.